(Total Views: 288)
Posted On: 05/19/2023 3:25:47 PM
Post# of 194

$ABBV News Article - EPKINLY(TM) (epcoritamab-bysp) Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) https://marketwirenews.com/news-releases/epki...54775.html


My Twitter: WhyteStocks